Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes

PY Law, DS Hom and HH Loh

Chronic treatment of neuroblastoma X glioma NG108-15 hybrid cells with the opiate agonist etorphine resulted in a decrease in both opiate receptor density (receptor down-regulation) and opiate ability to inhibit prostaglandin E1 (PGE1)-stimulated increases in cyclic AMP levels (receptor desensitization). Opiate receptor down-regulation and desensitization were homologous as indicated by the lack of apparent change in muscarinic, alpha 2-adrenergic, and PGE1 receptor binding and also retention, albeit modulation, of the ability of carbachol and norepinephrine to inhibit PGE1-stimulated increases in cyclic AMP levels after 24 hr of etorphine treatment. PGE1-stimulated increases in cyclic AMP levels remained identical in etorphine-treated and control cells. Several lines of evidence indicate that receptor desensitization and receptor down-regulation in NG108-15 cells are two separate cellular adaptation processes. (a) With an agonist which appears to be efficiently coupled, i.e., an agonist whose apparent Kd value is much larger than its apparent IC50 value for regulation of cyclic AMP levels (Ki), the concentration of ligand required to produce half-maximal down- regulation is analogous to its Ki value, whereas the concentration of ligand required to produce half-maximal desensitization is related to its Kd value; (b) receptor desensitization precedes receptor down- regulation; (c) only opiate agonists could produce receptor down- regulation, whereas both opiate agonists and partial agonists could desensitize post-receptor occupancy events. Still further evidence for dissociability of these processes was obtained by incubating NG108-15 cells with etorphine at 30 degrees for 2 hr. Under these conditions, there was a decrease in etorphine's ability to regulate adenylate cyclase while [3H]diprenorphine binding remained unaltered. IC50 values of D-Ala2-D-Leu5-enkephalin's competition for [3H]diprenorphine binding to intact cells increased 19.6-fold after etorphine treatment for 90 min, while naloxone IC50 values remained unaltered. This apparent increase in IC50 values was much lower, about 2-fold, when receptor binding was carried out in membranes isolated from cells treated with etorphine chronically. Furthermore, analysis of [3H]etorphine binding to such membranes in the presence of 10 mM Mg2+ indicated a loss of receptor binding sites with no change in apparent affinity, whereas [3H]diprenorphine binding revealed no significant alteration in either Bmax or Kd values. Therefore, during opiate receptor desensitization, a reduction of agonist high-affinity site occurs with no apparent alteration in total receptor number.

Volume 24, Issue 3, pp. 413-424, 11/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				P. N. Yadav, K. Chaturvedi, and R. D. Howells Inhibition of Agonist-Induced Down-Regulation of the {delta}-Opioid Receptor with a Proteasome Inhibitor Attenuates Opioid Tolerance in Human Embryonic Kidney 293 Cells J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1186 - 1194. [Abstract] [Full Text] [PDF]

				H. Zhao, H. H. Loh, and P. Y. Law Adenylyl Cyclase Superactivation Induced by Long-Term Treatment with Opioid Agonist Is Dependent on Receptor Localized within Lipid Rafts and Is Independent of Receptor Internalization Mol. Pharmacol., April 1, 2006; 69(4): 1421 - 1432. [Abstract] [Full Text] [PDF]

				P. A. Claude-Geppert, J. Liu, J. Solberg, L. J. Erickson-Herbrandson, H. H. Loh, and P.-Y. Law Antagonist Efficacy in MORS196L Mutant Is Affected by the Interaction between Transmembrane Domains of the Opioid Receptor J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 216 - 226. [Abstract] [Full Text] [PDF]

				P. Riba, Y. Ben, A. P. Smith, S. Furst, and N. M. Lee Morphine Tolerance in Spinal Cord Is Due to Interaction between {micro}- and delta -Receptors J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 265 - 272. [Abstract] [Full Text] [PDF]

				N. A. Martin, M. T. Terruso, and P. L. Prather Agonist Activity of the delta -Antagonists TIPP and TIPP-psi in Cellular Models Expressing Endogenous or Transfected delta -Opioid Receptors J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 240 - 248. [Abstract] [Full Text]

				L. J. Sim-Selley, D. E. Selley, L. J. Vogt, S. R. Childers, and T. J. Martin Chronic Heroin Self-Administration Desensitizes {micro} Opioid Receptor-Activated G-Proteins in Specific Regions of Rat Brain J. Neurosci., June 15, 2000; 20(12): 4555 - 4562. [Abstract] [Full Text] [PDF]

				P. I. Tsao and M. von Zastrow Type-specific Sorting of G Protein-coupled Receptors after Endocytosis J. Biol. Chem., April 6, 2000; 275(15): 11130 - 11140. [Abstract] [Full Text] [PDF]

				A. Hasbi, S. Allouche, F. Sichel, L. Stanasila, D. Massotte, G. Landemore, J. Polastron, and P. Jauzac Internalization and Recycling of delta -Opioid Receptor Are Dependent on a Phosphorylation-Dephosphorylation Mechanism J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 237 - 247. [Abstract] [Full Text]

				P.-Y. Law and H. H. Loh Regulation of Opioid Receptor Activities J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 607 - 624. [Abstract] [Full Text]

				R. El Kouhen, O. M.-E. Kouhen, P.-Y. Law, and H. H. Loh The Absence of a Direct Correlation between the Loss of [D-Ala2,MePhe4,Gly5-ol]Enkephalin Inhibition of Adenylyl Cyclase Activity and Agonist-induced µ-Opioid Receptor Phosphorylation J. Biol. Chem., April 2, 1999; 274(14): 9207 - 9215. [Abstract] [Full Text] [PDF]

				A. L. Burd, R. El-Kouhen, L. J. Erickson, H. H. Loh, and P.-Y. Law Identification of Serine 356 and Serine 363 as the Amino Acids Involved in Etorphine-induced Down-regulation of the µ-Opioid Receptor J. Biol. Chem., December 18, 1998; 273(51): 34488 - 34495. [Abstract] [Full Text] [PDF]

				D. Strassheim, P.-Y. Law, and H. H. Loh Contribution of Phospholipase C-beta 3 Phosphorylation to the Rapid Attenuation of Opioid-Activated Phosphoinositide Response Mol. Pharmacol., June 1, 1998; 53(6): 1047 - 1053. [Abstract] [Full Text]

				R. D. Polakiewicz, S. M. Schieferl, L. F. Dorner, V. Kansra, and M. J. Comb A Mitogen-activated Protein Kinase Pathway Is Required for µ-Opioid Receptor Desensitization J. Biol. Chem., May 15, 1998; 273(20): 12402 - 12406. [Abstract] [Full Text] [PDF]

				J. Zhu, L.-Y. Luo, G.-F. Mao, B. Ashby, and L.-Y. Liu-Chen Agonist-Induced Desensitization and Down-regulation of the Human Kappa Opioid Receptor Expressed in Chinese Hamster Ovary Cells J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 28 - 36. [Abstract] [Full Text]

				L. M. Harrison, A. J. Kastin, and J. E. Zadina Tyr-W-MIF-1 Attenuates Down-Regulation of Opiate Receptors in SH-SY5Y Human Neuroblastoma Cells J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 611 - 617. [Abstract] [Full Text]

				Y. Yu, L. Zhang, X. Yin, H. Sun, G. R. Uhl, and J. B. Wang µ Opioid Receptor Phosphorylation, Desensitization, and Ligand Efficacy J. Biol. Chem., November 14, 1997; 272(46): 28869 - 28874. [Abstract] [Full Text] [PDF]

				F. Noble and B. M. Cox The Role of Dopaminergic Systems in Opioid Receptor Desensitization in Nucleus Accumbens and Caudate Putamen of Rat After Chronic Morphine Treatment J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 557 - 565. [Abstract] [Full Text]

				N. Yabaluri and F. Medzihradsky Down-regulation of µ-Opioid Receptor by Full but Not Partial Agonists Is Independent of G Protein Coupling Mol. Pharmacol., November 1, 1997; 52(5): 896 - 902. [Abstract] [Full Text]

				S. Cvejic and L. A. Devi Dimerization of the delta  Opioid Receptor:. IMPLICATION FOR A ROLE IN RECEPTOR INTERNALIZATION J. Biol. Chem., October 24, 1997; 272(43): 26959 - 26964. [Abstract] [Full Text] [PDF]

				S. Chakrabarti, W. Yang, P.-Y. Law, and H. H. Loh The µ-Opioid Receptor Down-Regulates Differently from the delta -Opioid Receptor: Requirement of a High Affinity Receptor/G Protein Complex Formation Mol. Pharmacol., July 1, 1997; 52(1): 105 - 113. [Abstract] [Full Text]

				G. Gaudriault, D. Nouel, C. Dal Farra, A. Beaudet, and J.-P. Vincent Receptor-induced Internalization of Selective Peptidicµand delta Opioid Ligands J. Biol. Chem., January 31, 1997; 272(5): 2880 - 2888. [Abstract] [Full Text] [PDF]

				H. Ammer and R. Schulz Chronic Morphine Treatment Increases Stimulatory Beta-2 Adrenoceptor Signaling in A431 Cells Stably Expressing the Mu Opioid Receptor J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 512 - 520. [Abstract] [Full Text]

				R. El Kouhen, A. L. Burd, L. J. Erickson-Herbrandson, C.-Y. Chang, P.-Y. Law, and H. H. Loh Phosphorylation of Ser363, Thr370, and Ser375 Residues within the Carboxyl Tail Differentially Regulates {micro}-Opioid Receptor Internalization J. Biol. Chem., April 13, 2001; 276(16): 12774 - 12780. [Abstract] [Full Text] [PDF]